Heprajet 25000IU Injection

Heprajet 25000IU Injection contains an active component as Heparin. It is a widely used anticoagulant medication, meaning it prevents the formation of blood clots. It is commonly prescribed in various medical situations to reduce the risk of clotting, especially in patients who are at higher risk for developing blood clots. Heprajet 25000IU Injection is commonly used in hospitals to prevent and treat deep vein thrombosis (DVT), pulmonary embolism (PE), and other conditions where the formation of blood clots is a concern. It is also used during certain surgical procedures and in dialysis to prevent clotting in the extracorporeal circuit.  The effect varies among individuals, so its administration requires careful monitoring of blood clotting parameters, usually through the activated partial thromboplastin time (aPTT) test. The dosage may need to be adjusted to maintain therapeutic levels. In case of excessive bleeding or an overdose of Heprajet 25000IU Injection, its effects can be reversed using protamine sulfate, an antidote for heparin. Patients with known hypersensitivity or allergic reactions should not use Heprajet 25000IU Injection. While this medication is generally safe, it may not suit people with certain medical conditions, such as bleeding disorders or recent major surgeries. You must inform your healthcare provider about any existing medical conditions and medications you are taking before starting the therapy. Elderly individuals may be more susceptible to bleeding complications, and lower dosages or closer monitoring may be necessary. Impaired liver or kidney function can affect the metabolism and elimination of this medication, potentially leading to adverse effects. Dosing adjustments may be necessary for patients with these conditions.